Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Notable Labs

Explore full profile

Personalized drug combination testing service for cancer patients

Foster City, United StatesFounded 2014Biotech & Life Sciences
Revenue <$1M Latest reported FY
Headcount <100 Current team size
Total funding $50–100M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Notable Labs and the history behind them.

About Notable Labs

Notable Labs, Inc. is a clinical stage platform therapeutics company focused on developing predictive precision medicines for cancer patients. The company operates in the healthcare sector, specifically within the oncology market. Notable's core business model revolves around creating and commercializing targeted therapies that are designed to improve patient outcomes through precision medicine. This approach involves using data and advanced analytics to predict which treatments will be most effective for individual patients, thereby increasing the likelihood of success and reducing the risks associated with traditional drug development processes.

Read full description

Notable serves a diverse range of clients, including cancer patients, healthcare providers, and research institutions. The company generates revenue through the development and licensing of its proprietary medicines and technologies. By focusing on a de-risked in-licensing strategy, Notable aims to deliver medical impact and commercial value more efficiently and effectively than traditional methods.

Headquartered in Foster City, California, Notable Labs is committed to its values of mission over ego, scientific responsibility, perseverance with compassion, and relentless resourcefulness. The company has cultivated a workplace that emphasizes respect, safety, and inclusivity, which has enabled it to attract and retain top talent in the industry.

Source: Dealroom company data

At a glance

Founded
2014
Headquarters
Foster City, United States
Sector
Biotech & Life Sciences

Investors

23 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed14 investors entered at this stage

Series A9 investors entered at this stage

Team profiled 15 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇺🇸 United States87.5%
🇮🇳 India12.5%
2 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Notable Labs on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Notable Labs on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.